ARTICLE | Company News
Eye Therapies, Bausch + Lomb deal
January 14, 2013 8:00 AM UTC
Bausch + Lomb acquired an exclusive, worldwide license to Eye Therapies' technology to treat ocular redness. The product, which uses low-dose brimonidine, was developed with private research organizat...